Source: StreetInsider

Press Release: Amarex Clinical Research : US FDA Authorizes Launch of Clinical Trial to Support New Treatment Development for Progeria

New Trial to Study Progerinin Treatment for Ultra-Rare ConditionBUSAN, KOREA; PEABODY, MA; and GERMANTOWN, MD / ACCESSWIRE / October 2, 2024 / The United States Food and Drug Administration (FDA) has...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kazem Kazempour's photo - President & CEO of Amarex Clinical Research

President & CEO

Kazem Kazempour

CEO Approval Rating

69/100

Read more